XBI - SPDR Biotech ETF contains 127 holdings. The top holdings include EXAS, ALNY, NBIX, NTRA, UTHR
Name | Weight |
---|---|
3.28% | |
3.16% | |
2.98% | |
![]() | 2.80% |
2.68% | |
![]() | 2.66% |
![]() | 2.51% |
2.47% | |
![]() | 2.46% |
![]() | 2.39% |
2.38% | |
2.37% | |
![]() | 2.33% |
![]() | 2.32% |
2.29% | |
2.18% | |
1.91% | |
![]() | 1.83% |
1.71% | |
1.61% | |
1.53% | |
1.45% | |
1.36% | |
1.33% | |
1.33% | |
1.33% | |
1.28% | |
1.26% | |
![]() | 1.17% |
1.10% |
Sector | Weight |
---|---|
Health Care | 99.84% |
Name | Correlation | AUM | Expense Ratio | |
---|---|---|---|---|
VIXY | -58.06% | $109.64M | 0.85% | |
TAIL | -55.48% | $140.49M | 0.59% | |
BTAL | -51.65% | $361.41M | 1.43% | |
IVOL | -24.45% | $353.94M | 1.02% | |
FXY | -16.16% | $838.61M | 0.4% | |
TPMN | -16.08% | $31.54M | 0.65% | |
FTSD | -15.51% | $212.46M | 0.25% | |
ULST | -13.26% | $637.77M | 0.2% | |
XONE | -12.99% | $603.24M | 0.03% | |
SPTS | -11.78% | $5.76B | 0.03% | |
GBIL | -11.40% | $6.17B | 0.12% | |
SHYM | -11.12% | $322.93M | 0.35% | |
XHLF | -11.08% | $1.46B | 0.03% | |
CLIP | -8.57% | $1.50B | 0.07% | |
UTWO | -7.58% | $387.71M | 0.15% | |
BIL | -7.44% | $45.95B | 0.1356% | |
CTA | -7.22% | $1.05B | 0.76% | |
TFLO | -6.99% | $7.06B | 0.15% | |
IBTG | -6.60% | $1.88B | 0.07% | |
TBLL | -6.14% | $2.46B | 0.08% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
EXC | 0.47% | $43.84B | +12.45% | 3.59% |
MSIF | 0.83% | $715.25M | +28.42% | 7.05% |
ZCMD | 1.09% | $32.45M | -11.38% | 0.00% |
KR | 1.20% | $44.68B | +24.17% | 1.89% |
MO | 1.23% | $97.80B | +26.35% | 6.94% |
MKTX | -1.29% | $8.01B | -1.42% | 1.39% |
AQB | -1.51% | $2.96M | -61.58% | 0.00% |
NEUE | -1.91% | $62.05M | +13.56% | 0.00% |
AIFU | -2.08% | $9.85M | -95.03% | 0.00% |
PSQH | 2.18% | $89.26M | -49.87% | 0.00% |
HEES | 2.19% | $3.52B | +99.54% | 1.15% |
VSTA | -2.73% | $326.82M | +11.64% | 0.00% |
BTCT | -2.74% | $25.35M | +93.08% | 0.00% |
PULM | 2.79% | $23.82M | +239.64% | 0.00% |
STG | -3.16% | $27.05M | -37.35% | 0.00% |
AWK | 3.44% | $27.37B | +4.54% | 2.22% |
ED | -3.54% | $36.75B | +5.26% | 3.28% |
VHC | -3.63% | $34.69M | +74.89% | 0.00% |
PPC | 3.74% | $11.21B | +41.54% | 0.00% |
DG | 4.08% | $20.45B | -36.56% | 2.55% |
Name | Correlation | AUM | Expense Ratio | |
---|---|---|---|---|
FXE | 0.03% | $525.40M | 0.4% | |
GSST | 0.12% | $857.21M | 0.16% | |
LDUR | 0.25% | $849.09M | 0.5% | |
UDN | 0.39% | $137.74M | 0.78% | |
IEI | 0.40% | $16.09B | 0.15% | |
WEAT | 0.62% | $115.83M | 0.28% | |
IBTJ | 0.78% | $658.04M | 0.07% | |
IBTI | -0.78% | $995.39M | 0.07% | |
BWX | 1.00% | $1.41B | 0.35% | |
XBIL | -1.10% | $782.40M | 0.15% | |
UUP | -1.14% | $292.27M | 0.77% | |
JMST | -1.18% | $3.65B | 0.18% | |
AGZ | 1.38% | $607.46M | 0.2% | |
SMB | 1.95% | $269.10M | 0.07% | |
VGIT | 2.26% | $31.33B | 0.04% | |
IBTK | 2.27% | $431.59M | 0.07% | |
CARY | 2.32% | $347.36M | 0.8% | |
VTIP | 2.41% | $14.78B | 0.03% | |
USDU | -2.53% | $173.44M | 0.5% | |
FTSM | 2.59% | $6.54B | 0.45% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
DNLI | 73.23% | $2.06B | -30.04% | 0.00% |
KRYS | 71.31% | $3.77B | -20.42% | 0.00% |
CRNX | 70.85% | $2.92B | -39.88% | 0.00% |
IDYA | 70.81% | $1.52B | -58.32% | 0.00% |
BEAM | 70.09% | $1.73B | -27.49% | 0.00% |
KYMR | 69.82% | $1.95B | -15.67% | 0.00% |
ROIV | 69.22% | $7.68B | -5.70% | 0.00% |
RCKT | 68.89% | $724.54M | -71.26% | 0.00% |
ACLX | 67.62% | $3.22B | +10.72% | 0.00% |
CRSP | 66.40% | $3.14B | -34.78% | 0.00% |
RVMD | 66.37% | $7.35B | +1.15% | 0.00% |
NTLA | 65.76% | $836.43M | -69.14% | 0.00% |
XNCR | 65.64% | $583.60M | -63.49% | 0.00% |
TECH | 65.14% | $7.56B | -41.77% | 0.49% |
SYRE | 65.09% | $877.54M | -61.53% | 0.00% |
ARWR | 64.87% | $2.12B | -38.64% | 0.00% |
IMNM | 64.57% | $696.10M | -44.44% | 0.00% |
APGE | 64.46% | $2.42B | -24.39% | 0.00% |
XENE | 64.41% | $2.27B | -26.70% | 0.00% |
COGT | 64.18% | $543.09M | -36.14% | 0.00% |
Name | Correlation | AUM | Expense Ratio | |
---|---|---|---|---|
IBB | 94.18% | $5.22B | 0.45% | |
PBE | 90.63% | $214.12M | 0.58% | |
GNOM | 90.58% | $40.65M | 0.5% | |
FBT | 86.14% | $994.71M | 0.56% | |
BBH | 85.97% | $327.42M | 0.35% | |
ARKG | 83.24% | $944.78M | 0.75% | |
PTH | 82.14% | $96.56M | 0.6% | |
PINK | 81.56% | $131.52M | 0.5% | |
XPH | 78.12% | $136.58M | 0.35% | |
IWO | 77.60% | $11.36B | 0.24% | |
IWC | 75.82% | $766.88M | 0.6% | |
FXH | 75.61% | $891.82M | 0.62% | |
KJUL | 75.36% | $113.35M | 0.79% | |
QQQJ | 75.33% | $610.08M | 0.15% | |
VTWO | 74.94% | $12.07B | 0.07% | |
IWM | 74.84% | $63.95B | 0.19% | |
ISCG | 74.66% | $645.00M | 0.06% | |
VBK | 74.58% | $18.33B | 0.07% | |
SCHA | 74.04% | $16.91B | 0.04% | |
KJAN | 73.91% | $305.13M | 0.79% |
Current Value
$77.871 Year Return
Current Value
$77.871 Year Return
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
FMTO | -16.17% | $45.74M | -99.96% | 0.00% |
CBOE | -12.95% | $22.95B | +20.67% | 1.12% |
LITB | -11.53% | $21.28M | -72.45% | 0.00% |
K | -7.35% | $28.49B | +32.17% | 2.77% |
CME | -5.07% | $98.74B | +28.80% | 3.84% |
VSA | -4.57% | $7.04M | -49.24% | 0.00% |
VHC | -3.63% | $34.69M | +74.89% | 0.00% |
ED | -3.54% | $36.75B | +5.26% | 3.28% |
STG | -3.16% | $27.05M | -37.35% | 0.00% |
BTCT | -2.74% | $25.35M | +93.08% | 0.00% |
VSTA | -2.73% | $326.82M | +11.64% | 0.00% |
AIFU | -2.08% | $9.85M | -95.03% | 0.00% |
NEUE | -1.91% | $62.05M | +13.56% | 0.00% |
AQB | -1.51% | $2.96M | -61.58% | 0.00% |
MKTX | -1.29% | $8.01B | -1.42% | 1.39% |
EXC | 0.47% | $43.84B | +12.45% | 3.59% |
MSIF | 0.83% | $715.25M | +28.42% | 7.05% |
ZCMD | 1.09% | $32.45M | -11.38% | 0.00% |
KR | 1.20% | $44.68B | +24.17% | 1.89% |
MO | 1.23% | $97.80B | +26.35% | 6.94% |
SeekingAlpha
Discover insights on the 4-week market rally as tariff worries ease. Learn about sector performance, stock trends, and key trade negotiation impacts.
SeekingAlpha
Avoid FOMO trading! Learn how model-based strategies, Momentum Gauges, & sector rotations unlock gains in record volatility.
SeekingAlpha
When Trump Says 'Buy,' You Buy
SeekingAlpha
Trump aims to cut US drug prices by 30-80% via Executive Order. Check out how pharma companies could be affected and how this may play out in the future.
SeekingAlpha
Explore XBI's solid valuation, technical risks, and sector challenges amid macroeconomic uncertainty.
SeekingAlpha
Intellia Therapeutics reported further progress with two treatments that are now ensconced in Phase III of testing. Click here to see why NTLA stock is a Buy.